Recall
FDAHealthAugust 22, 2024

ProRx LLC — Semaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial, ProRx, 267-565-7008, NDC 84139-225-01

⚠️ Lack of Assurance of Sterility

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
August 22, 2024

Nationwide in the USA

What's affected?

Product
Semaglutide, 2 mL (2.5mg/mL), Compounded RX Product, Multidose SC inj, glass vial, ProRx, 267-565-7008, NDC 84139-225-01
Lot code
ProRx031924

Additional details

Lot #: ProRx031924, BUD 09/18/2024 ProRx032624, BUD 09/25/2024 ProRx041324, BUD 10/12/2024

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 2,490 vials.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.